Abstract
The CSF-1 receptor is a protein-tyrosine kinase that has been shown to undergo regulated intramembrane proteolysis, or RIPping. Here, we have compared receptor downregulation and RIPping in response to CSF-1 and TPA. Our studies show that CSF-1 is a relatively poor inducer of RIPping and that CSF-1-induced receptor downregulation is largely independent of RIPping. TPA is a strong inducer of RIPping and TPA-induced receptor downregulation is mediated by RIPping. We further found that RIPping is dependent on TACE or a TACE-like protease, that CSF-1 and TPA use independent pathways to initiate RIPping, and that the intracellular domain is targeted for degradation through ubiquitination.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ADAM Proteins / antagonists & inhibitors
-
ADAM Proteins / metabolism
-
ADAM17 Protein
-
Animals
-
Cell Line
-
Down-Regulation / drug effects
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Intracellular Membranes / drug effects*
-
Intracellular Membranes / metabolism*
-
Lysosomes / drug effects
-
Lysosomes / metabolism*
-
Macrophage Colony-Stimulating Factor / pharmacology*
-
Mice
-
Phorbol Esters / pharmacology*
-
Receptor, Macrophage Colony-Stimulating Factor / metabolism*
-
Signal Transduction / drug effects*
-
Time Factors
-
Ubiquitination
Substances
-
Enzyme Inhibitors
-
Phorbol Esters
-
phorbol 12,13,20-triacetate
-
Macrophage Colony-Stimulating Factor
-
Receptor, Macrophage Colony-Stimulating Factor
-
ADAM Proteins
-
ADAM17 Protein
-
ADAM17 protein, human
-
Adam17 protein, mouse